SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=